Published in Scand J Haematol on January 01, 1973
The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor. J Exp Med (1969) 2.39
Attitudes of patients to clinical teaching. Br J Med Educ (1967) 2.28
Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors. J Clin Invest (1969) 2.14
Effects of lecture information density on medical student achievement. J Med Educ (1984) 2.06
Postgraduate medical degrees of the University of Aberdeen, 1931-69. Scott Med J (1970) 1.64
Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease. J Clin Pathol (1966) 1.55
Medicare payment policy and recombinant erythropoietin prescribing for dialysis patients. Am J Kidney Dis (1993) 1.48
Venous thrombosis following strokes. Lancet (1972) 1.46
Medical-resource use for suspected tuberculosis in a New York City hospital. Infect Control Hosp Epidemiol (1998) 1.42
Familial thrombosis: inherited deficiency of antithrombin III. Br Med J (1978) 1.40
Studies on the blood fibrinolytic enzyme system following acute myocardial infarction. Clin Sci (1967) 1.26
Further medical education of Aberdeen graduates 1956-58. Br J Med Educ (1969) 1.18
Deep venous thrombosis of the legs after strokes. Part I--incidence and predisposing factors. Br Med J (1976) 1.15
Access to recombinant erythropoietin by Medicare-entitled dialysis patients in the first year after FDA approval. JAMA (1992) 1.13
The assay of a plasma component necessary for the generation of a plasminogen activator in the presence of Hageman factor (Hageman factor co-factor). Br J Haematol (1971) 1.12
A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction. Lancet (1973) 1.11
Serum Mucoproteins and Plasma Fibrinolytic Activity in Coronary-artery Disease. Br Med J (1962) 1.10
The relationship between platelet aggregation and time interval after venepuncture. Thromb Diath Haemorrh (1974) 1.08
Early dosing practices and effectiveness of recombinant human erythropoietin. Kidney Int (1993) 1.07
Present employment of University of Aberdeen medical graduates, 1956-58. Lancet (1969) 1.06
The respiratory effects of volatile organic compounds. Int J Occup Environ Health (2000) 1.00
A four-year longitudinal study of dental student learning styles. J Dent Educ (1987) 0.99
The inhibition of urokinase by alpha 2 -macroglobulin. Clin Sci (1973) 0.97
The plasminogen content of thrombi. Thromb Diath Haemorrh (1966) 0.96
Studies on the fibrinolytic enzyme system in obesity. J Clin Pathol (1966) 0.94
Effect of recombinant erythropoietin on hospital admissions, readmissions, length of stay, and costs of dialysis patients. J Am Soc Nephrol (1994) 0.93
The relationship of provider organizational status and erythropoietin dosing in end stage renal disease patients. Med Care (1994) 0.93
The metabolism of Plasmodium berghei, the malaria parasite of rodents. 2. An effect of mepacrine on the metabolism of glucose by the parasite separated from its host cell. Biochem J (1961) 0.93
Evaluation of diagnostic significance of certain symptoms and physical signs in anaemic patients. Br Med J (1969) 0.92
Inhibitors of the fibrinolytic enzyme system in renal disease. Clin Sci (1970) 0.92
Psychogenic purpura. Br Med J (1971) 0.91
Effect of oestriol on platelet adhesiveness and fibrinolysis in men. Lancet (1966) 0.91
Effect of exercise on platelet count, adhesion, and aggregation. Acta Haematol (1974) 0.91
High incidence of myelomatosis in North-East Scotland. Scott Med J (1973) 0.90
Deep venous thrombosis of the legs after strokes: Part 2-Natural history. Br Med J (1976) 0.90
Economic impact of immunization against rotavirus gastroenteritis. Evidence from a clinical trial. Arch Pediatr Adolesc Med (1995) 0.90
Platelet adhesiveness, coagulation, and fibrinolytic activity in obesity. J Clin Pathol (1972) 0.90
Factors influencing the prognosis in myelomatosis. Postgrad Med J (1971) 0.90
Sequential studies on components of the haemostatic mechanism in pregnancy with particular reference to the development of pre-eclampsia. Br J Obstet Gynaecol (1976) 0.90
Methotrexate and the platelet count. Br J Cancer (1968) 0.88
The inhibition of tissue activator and urokinase by human plasma. Thromb Haemost (1982) 0.88
Coagulation and fibrinolysis in thyroid disease. Acta Haematol (1978) 0.87
Surface-mediated reactions in the formation of thrombin, plasmin and kallikrein. Br Med Bull (1978) 0.87
Technetium-99m in the diagnosis of left-to-right shunts. Thorax (1966) 0.86
The inhibition by plasma of urokinase and tissue activator-induced fibrinolysis in pregnancy and the puerperium. Thromb Haemost (1983) 0.86
The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastases. J Clin Pathol (1971) 0.86
Studies on an inhibitor of plasminogen activators in human platelets. Br J Haematol (1974) 0.85
Arcus senilis and coronary artery disease. Am Heart J (1965) 0.85
The contribution of plasma protease inhibitors to antiplasmin activity in man. Clin Sci Mol Med (1976) 0.84
Blood levels of proteinase inhibitors in pre-eclampsia. Br J Obstet Gynaecol (1983) 0.83
Inhibitors of plasminogen activation in human blood. Br J Haematol (1976) 0.83
Blood levels of proteinase inhibitors in pregnancy. Br J Obstet Gynaecol (1982) 0.83
Changes in protease inhibitors after acute myocardial infarction. J Clin Pathol (1976) 0.82
Metabolic behavior and radiation dosimetry of 99mTc-albumin in pregnancy. J Nucl Med (1969) 0.82
The action of antithrombin III on plasmin and activators of plasminogen. Biochim Biophys Acta (1975) 0.82
Arterio-venous differences in the components of the fibrinolytic enzyme system. Thromb Diath Haemorrh (1966) 0.81
Traumatic abdominal wall hernia in a 7-year-old child. J Pediatr Surg (1973) 0.81
Medical resource use and costs among rheumatoid arthritis patients receiving disease-modifying antirheumatic drug therapy. Arthritis Care Res (2000) 0.81
The effect of age on the fibrinolytic enzyme system. J Clin Pathol (1974) 0.80
C1 inactivator level in pregnancy. Thromb Res (1982) 0.80
The influence of alpha-1-antitrypsin on plasmin, urokinase and Hageman factor cofactor. Biochim Biophys Acta (1974) 0.80
The influence of the platelet count on the incidence of thrombotic and haemorrhagic complications in polycythaemia vera. Postgrad Med J (1970) 0.80
Differential expression of putative floral genes in Pharbitis nil shoot apices cultured on glucose compared with sucrose. J Exp Bot (2004) 0.79
Properties of a partially purified preparation of a circulating plasminogen activator. Thromb Res (1976) 0.79
Urokinase in iliofemoral venous thrombosis. Br J Surg (1969) 0.79
The effect of age upon the coagulation system. J Clin Pathol (1974) 0.77
The fibrinolytic system in pre-eclampsia. J Clin Pathol (1984) 0.77
Platelet adhesiveness and fibrinolysis after recent cerebro-vascular accidents and their relationship with subsequent deep venous thrombosis of the legs. Thromb Haemost (1976) 0.77
An evaluation of the diagnostic significance of some symptoms and physical signs in chronic iron-deficiency anaemia. Proc Nutr Soc (1969) 0.76
The influence of the polyphenols of cider on plasmin and plasminogen activators. Br J Haematol (1985) 0.76
Changes in coagulation factors following acute myocardial infarction in man. Haemostasis (1976) 0.76
The determination time of the carpel whorl is differentially sensitive to carbohydrate supply in Pharbitis nil. Plant Physiol (2000) 0.76
The effeCt of vitamin c supplements on serum cholesterol, coagulation, fibrinolysis and platelet adhesiveness. Atherosclerosis (1975) 0.76
The effect of prolonged exercise on the components of the blood fibrinolytic enzyme system. J Physiol (1968) 0.76
Fibrinolytic capacity of arm and leg veins after femoral shaft fracture and acute myocardial infarction. Br Med J (1975) 0.75
The fibrinolytic enzyme system in hypertension. J Clin Pathol (1973) 0.75
Biochemistry of the plasmin system. J Clin Pathol Suppl (R Coll Pathol) (1980) 0.75
Thrombocytosis following thrombocytopenia in man. Postgrad Med J (1969) 0.75
Effect of local exercise and vessel occlusion on fibrinolytic activity. J Clin Pathol (1977) 0.75
Origin and employment of the medical graduates of the University of Aberdeen 1931-69. Br Med J (1970) 0.75
Fibrinolysis in leukaemia. J Clin Pathol (1968) 0.75
Fibrinolytic activity in malignant disease. J Clin Pathol (1975) 0.75
Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects. Drugs (1971) 0.75
Paralysis of the legs and venous thromboembolism. Am Heart J (1973) 0.75
An artificial circulation for the study of thrombolysis. The influence of flow rate and pressure on thrombolysis and a comparison between urokinase and tissue activator as thrombolytic agents. Acta Haematol (1983) 0.75
The influence of personality on student reactions to clinical experience. J Med Educ (1972) 0.75
Anticoagulant and thrombolytic drugs. II. Clinical aspects. Drugs (1971) 0.75
Influence of social desirability upon the group personality projective test. Psychol Rep (1971) 0.75
Properties of plasma plasminogen activators [proceedings]. J Physiol (1978) 0.75
The effect of clofibrate on components of the fibrinolytic enzyme system. Atherosclerosis (1973) 0.75
Inhibition of the plasminogen activator urokinase by alpha-tocopherol. Acta Haematol (1982) 0.75
Inhibition of the activated Cls subunit of the first component of complement by antithrombin III in the presence of heparin. Thromb Res (1976) 0.75
Influence of cider on the fibrinolytic enzyme system. Acta Haematol (1983) 0.75
The effect of age on the diagnostic value of greying of the hair in addisonian pernicious anaemia. Gerontol Clin (Basel) (1972) 0.75
Further purification and properties of Hageman factor cofactor. Biochim Biophys Acta (1972) 0.75
Inhibitors of fibrinolysis in amniotic fluid. Thromb Haemost (1980) 0.75
Interrelations between ABO blood group, plasminogen, alpha1-antitrypsin, alpha2-macroglobulin and the platelet count in blood donors. Acta Haematol (1976) 0.75
Clinical physiology of the fibrinolytic enzyme system. J Clin Pathol (1972) 0.75
The fibrinolytic enzyme system in leukaemia, myelomatosis and myeloproliferative diseases. Acta Haematol (1972) 0.75